{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:15:05Z","timestamp":1790342105130,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","award":["#01\/2013 BRA\/K57"],"award-info":[{"award-number":["#01\/2013 BRA\/K57"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["#402004\/2012-4, #454931\/2014-0"],"award-info":[{"award-number":["#402004\/2012-4, #454931\/2014-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Secretaria de Vigil\u00e2ncia em Sa\u00fade","award":["#281\/2013"],"award-info":[{"award-number":["#281\/2013"]}]},{"name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","award":["E-26\/110.261\/2014"],"award-info":[{"award-number":["E-26\/110.261\/2014"]}]},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","award":["#2012\/51743-0"],"award-info":[{"award-number":["#2012\/51743-0"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0221281","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T17:39:46Z","timestamp":1566409186000},"page":"e0221281","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":38,"title":["Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0045-6764","authenticated-orcid":true,"given":"Luana M. S.","family":"Marins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago S.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuri da C.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo I.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula M.","family":"Luz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Hoagland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-6925","authenticated-orcid":true,"given":"Esper G.","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Valdez","family":"Madruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Grinsztejn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valdilea G.","family":"Veloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"issue":"2","key":"pone.0221281.ref001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s15010-015-0850-2","article-title":"HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans","volume":"44","author":"CD Spinner","year":"2016","journal-title":"Infection"},{"issue":"27","key":"pone.0221281.ref002","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men","volume":"363","author":"RM Grant","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"pone.0221281.ref003","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"RM Grant","year":"2014","journal-title":"The Lancet Infectious Diseases"},{"issue":"10013","key":"pone.0221281.ref004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"S McCormack","year":"2016","journal-title":"The Lancet"},{"issue":"23","key":"pone.0221281.ref005","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1","volume":"373","author":"J-M Molina","year":"2015","journal-title":"Infection. New England Journal of Medicine"},{"issue":"5","key":"pone.0221281.ref006","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana","volume":"367","author":"MC Thigpen","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"pone.0221281.ref007","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/QAI.0000000000000212","article-title":"An Intervention to Support HIV Preexposure Prophylaxis Adherence in HIV-Serodiscordant Couples in Uganda","volume":"66","author":"C Psaros","year":"2014","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"pone.0221281.ref008","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women","volume":"367","author":"JM Baeten","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"pone.0221281.ref009","unstructured":"FDA. Truvada for PrEP Fact Sheet: Ensuring Safe and Proper Use [Internet]. 2012 [cited 2018 Oct 26]. https:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/UCM312290.pdf"},{"key":"pone.0221281.ref010","unstructured":"WHO. Brazil begins PrEP roll-out on World AIDS Day [Internet]. World Health Organization. 2017 [cited 2018 Oct 29]. http:\/\/www.who.int\/hiv\/mediacentre\/news\/brazil-prep\/en\/"},{"issue":"3","key":"pone.0221281.ref011","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1016\/S2352-3018(18)30011-0","article-title":"\u00a1PrEP Ya! Latin America wants PrEP, and Brazil leads the way","volume":"5","author":"JT Galea","year":"2018","journal-title":"The Lancet HIV"},{"issue":"8","key":"pone.0221281.ref012","doi-asserted-by":"crossref","first-page":"e009021","DOI":"10.1136\/bmjopen-2015-009021","article-title":"Pre-exposure and postexposure prophylaxes and the combination HIV prevention methods (The Combine! Study): protocol for a pragmatic clinical trial at public healthcare clinics in Brazil","volume":"5","author":"A Grangeiro","year":"2015","journal-title":"BMJ Open"},{"key":"pone.0221281.ref013","unstructured":"Minist\u00e9rio da Sa\u00fade publica protocolo para utiliza\u00e7\u00e3o da PrEP [Internet]. [cited 2019 May 18]. http:\/\/portalms.saude.gov.br\/noticias\/agencia-saude\/28555-ministerio-da-saude-publica-protocolo-para-utilizacao-da-prep"},{"issue":"3","key":"pone.0221281.ref014","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2352-3018(18)30008-0","article-title":"Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study","volume":"5","author":"B Grinsztejn","year":"2018","journal-title":"The Lancet HIV"},{"key":"pone.0221281.ref015","unstructured":"PAHO\/WHO | Brazil initiated the implementation of PrEP to prevent new cases of HIV among key higher-risk population groups [Internet]. [cited 2019 May 17]. https:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=14039:brazil-initiated-the-implementation-of-prep-to-prevent-new-cases-of-hiv-among-key-higher-risk-population-groups&Itemid=135&lang=en"},{"key":"pone.0221281.ref016","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/MD.0000000000010602","article-title":"PrEP adopted by the brazilian national health system: What is the size of the demand?","volume":"97","author":"PM Luz","year":"2018","journal-title":"Medicine"},{"key":"pone.0221281.ref017","unstructured":"PrEP\u2014O ESTADO DE IMPLEMENTA\u00c7\u00c3O DA PREP NO BRASIL | Boletim Vacinas Anti-HIV\/AIDS n\u00b032\u2014Fevereiro de 2019\u2014| GIV\u2014Grupo de Incentivo \u00e0 Vida [Internet]. [cited 2019 May 18]. http:\/\/giv.org.br\/boletimvacinas\/32\/08-prep-implementacao-no-brasil.php"},{"issue":"1","key":"pone.0221281.ref018","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAI.0000000000000386","article-title":"Comparing the Novel Method of Assessing PrEP Adherence\/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures","volume":"68","author":"SM Baxi","year":"2015","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"pone.0221281.ref019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAI.0000000000000479","article-title":"High Interest in Preexposure Prophylaxis Among Men Who Have Sex With Men at Risk for HIV Infection: Baseline Data From the US PrEP Demonstration Project","volume":"68","author":"SE Cohen","year":"2015","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"pone.0221281.ref020","unstructured":"T.S. Torres, L.M.S. Marins, P.M. Luz, R.I. Moreira, I.D. Costa Leite, B. Hoagland, et al. Predictors of self-reported adherence to pre-exposure prophylaxis (PrEP), including barriers and facilitators, among men who have sex with men (MSM) and transgender women (TGW): PrEP Brasil Demonstration Study. In: AIDS 2018 [Internet]. Amsterdam; 2018. http:\/\/programme.aids2018.org\/Abstract\/Abstract\/147"},{"key":"pone.0221281.ref021","article-title":"Awareness and factors associated with willingness to use Pre-exposure prophylaxis (PrEP) in Brazil, Mexico and Peru: an online survey among men who have sex with men (MSM)","author":"TS Torres","year":"2019","journal-title":"JMIR Public Health and Surveillance"},{"issue":"151","key":"pone.0221281.ref022","doi-asserted-by":"crossref","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men","volume":"4","author":"PL Anderson","year":"2012","journal-title":"Science Translational Medicine"},{"issue":"1","key":"pone.0221281.ref023","doi-asserted-by":"crossref","first-page":"e83736","DOI":"10.1371\/journal.pone.0083736","article-title":"Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)","volume":"9","author":"AY Liu","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"pone.0221281.ref024","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10461-012-0172-7","article-title":"A Proposal for Quality Standards for Measuring Medication Adherence in Research","volume":"17","author":"AB Williams","year":"2013","journal-title":"AIDS and Behavior"},{"issue":"5","key":"pone.0221281.ref025","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/cid\/ciu916","article-title":"Dose Response for Starting and Stopping HIV Preexposure Prophylaxis for Men Who Have Sex With Men","volume":"60","author":"SM Seifert","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"11","key":"pone.0221281.ref026","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/QAD.0000000000000647","article-title":"Defining success with HIV pre-exposure prophylaxis: a prevention-effective adherence paradigm","volume":"29","author":"JE Haberer","year":"2015","journal-title":"AIDS"},{"issue":"Supplement 1","key":"pone.0221281.ref027","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","article-title":"Practical and Conceptual Challenges in Measuring Antiretroviral Adherence","volume":"43","author":"KM Berg","year":"2006","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"pone.0221281.ref028","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/COH.0000000000000220","article-title":"Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice","volume":"11","author":"JE Haberer","year":"2016","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"1","key":"pone.0221281.ref029","doi-asserted-by":"crossref","first-page":"21472","DOI":"10.7448\/IAS.20.1.21472","article-title":"High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV Infection: the PrEP Brasil demonstration project","volume":"20","author":"B Hoagland","year":"2017","journal-title":"Journal of the International AIDS Society"},{"issue":"5","key":"pone.0221281.ref030","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/QAI.0000000000000216","article-title":"Study Product Adherence Measurement in the iPrEx Placebo-Controlled Trial: Concordance With Drug Detection","volume":"66","author":"KR Amico","year":"2014","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"key":"pone.0221281.ref031","article-title":"Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure","author":"JR Castillo-Mancilla","year":"2012","journal-title":"AIDS Research and Human Retroviruses"},{"key":"pone.0221281.ref032","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","article-title":"Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots","volume":"122","author":"J-H Zheng","year":"2016","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"9","key":"pone.0221281.ref033","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"RM Grant","year":"2014","journal-title":"The Lancet Infectious Diseases"},{"issue":"8","key":"pone.0221281.ref034","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1177\/0962280216680383","article-title":"The choice of methods in determining the optimal cut-off value for quantitative diagnostic test evaluation","volume":"27","author":"K Hajian-Tilaki","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"pone.0221281.ref035","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/bimj.200410135","article-title":"Estimation of the Youden Index and its Associated Cutoff Point","volume":"47","author":"R Fluss","year":"2005","journal-title":"Biom J"},{"issue":"2","key":"pone.0221281.ref036","first-page":"627","article-title":"Receiver Operating Characteristic (ROC) Curve Analysis for Medical Diagnostic Test Evaluation","volume":"4","author":"K Hajian-Tilaki","year":"2013","journal-title":"Caspian J Intern Med"},{"issue":"3","key":"pone.0221281.ref037","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach","volume":"44","author":"ER DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"3","key":"pone.0221281.ref038","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/QAI.0000000000000158","article-title":"FEM-PrEP: Adherence Patterns and Factors Associated With Adherence to a Daily Oral Study Product for Pre-exposure Prophylaxis","volume":"66","author":"AL Corneli","year":"2014","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"5","key":"pone.0221281.ref039","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure Prophylaxis for HIV Infection among African Women","volume":"367","author":"L Van Damme","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"pone.0221281.ref040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services","volume":"176","author":"AY Liu","year":"2016","journal-title":"JAMA Internal Medicine"},{"issue":"6","key":"pone.0221281.ref041","doi-asserted-by":"crossref","first-page":"e0157742","DOI":"10.1371\/journal.pone.0157742","article-title":"Adherence to Pre-Exposure Prophylaxis for HIV Prevention in a Clinical Setting","volume":"11","author":"MC Montgomery","year":"2016","journal-title":"PLOS ONE"},{"issue":"7","key":"pone.0221281.ref042","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/QAD.0000000000001024","article-title":"Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa","volume":"30","author":"N Musinguzi","year":"2016","journal-title":"AIDS"},{"issue":"9","key":"pone.0221281.ref043","doi-asserted-by":"crossref","first-page":"e1001511","DOI":"10.1371\/journal.pmed.1001511","article-title":"Adherence to Antiretroviral Prophylaxis for HIV Prevention: A Substudy Cohort within a Clinical Trial of Serodiscordant Couples in East Africa","volume":"10","author":"JE Haberer","year":"2013","journal-title":"PLoS Medicine"},{"issue":"5","key":"pone.0221281.ref044","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAI.0000000000001129","article-title":"Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation","volume":"73","author":"JL Marcus","year":"2016","journal-title":"JAIDS Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"pone.0221281.ref045","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1007\/s10461-017-1958-4","article-title":"Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data","volume":"22","author":"Z Baker","year":"2018","journal-title":"AIDS and Behavior"},{"issue":"5","key":"pone.0221281.ref046","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s10461-014-0891-z","article-title":"Factors Associated with Adherence and Concordance Between Measurement Strategies in an HIV Daily Oral Tenofovir\/Emtricitibine as Pre-exposure Prophylaxis (Prep) Clinical Trial, Botswana, 2007\u20132010","volume":"19","author":"PM Kebaabetswe","year":"2015","journal-title":"AIDS and Behavior"},{"issue":"7","key":"pone.0221281.ref047","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s10461-016-1360-7","article-title":"Self-reported Recent PrEP Dosing and Drug Detection in an Open Label PrEP Study","volume":"20","author":"For the iPrEx Study Team","year":"2016","journal-title":"AIDS and Behavior"},{"key":"pone.0221281.ref048","unstructured":"World Health Organization. Consultation on pre-exposure prophylaxis (PrEP) adherence: meeting report. World Health Organization; 2014."},{"issue":"4","key":"pone.0221281.ref049","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s10461-017-1951-y","article-title":"Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value","volume":"22","author":"A Abaasa","year":"2018","journal-title":"AIDS and Behavior"},{"issue":"6","key":"pone.0221281.ref050","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/COH.0b013e3283582d4a","article-title":"Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness","volume":"7","author":"KR Amico","year":"2012","journal-title":"Current Opinion in HIV and AIDS"},{"issue":"5","key":"pone.0221281.ref051","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10461-014-0859-z","article-title":"Accuracy of Self-Report and Pill-Count Measures of Adherence in the FEM-PrEP Clinical Trial: Implications for Future HIV-Prevention Trials","volume":"19","author":"K Agot","year":"2015","journal-title":"AIDS and Behavior"},{"key":"pone.0221281.ref052","unstructured":"Castillo-Mancilla JR, Haberer JE. Adherence Measurements in HIV: New Advancements in Pharmacologic Methods and Real-Time Monitoring. Current HIV\/AIDS Reports [Internet]. 2018 Jan 29 [cited 2018 Apr 10]; http:\/\/link.springer.com\/10.1007\/s11904-018-0377-0"},{"issue":"2","key":"pone.0221281.ref053","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/2325957414557263","article-title":"Self-Report Measures in the Assessment of Antiretroviral Medication Adherence: Comparison with Medication Possession Ratio and HIV Viral Load","volume":"14","author":"L Kabore","year":"2015","journal-title":"Journal of the International Association of Providers of AIDS Care (JIAPAC)"},{"key":"pone.0221281.ref054","unstructured":"Sistema de Controle Log\u00edstico de Medicamentos (SICLOM) [Internet]. Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das IST, HIV\/Aids e Hepatites Virais. [cited 2018 Dec 5]. http:\/\/www.aids.gov.br\/pt-br\/gestores\/sistemas-de-informacao\/sistema-de-controle-logistico-de-medicamentos-siclom"},{"key":"pone.0221281.ref055","unstructured":"D\u2019Alessandro A, Liumbruno GM, Grazzini G, Zolla L. Red blood cell storage: the story so far. Blood Transfusion [Internet]. 2010 [cited 2019 May 29]; http:\/\/doi.org\/10.2450\/2009.0122-09"},{"issue":"1","key":"pone.0221281.ref056","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01710-17","article-title":"Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy","volume":"62","author":"PL Anderson","year":"2017","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pone.0221281.ref057","doi-asserted-by":"crossref","first-page":"e25148","DOI":"10.1002\/jia2.25148","article-title":"Oral abstracts of the 22nd International AIDS Conference, 23\u201327 July 2018, Amsterdam, the Netherlands","volume":"21","year":"2018","journal-title":"Journal of the International AIDS Society"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0221281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T16:49:54Z","timestamp":1589042994000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0221281"}},"subtitle":[],"editor":[{"given":"Rupa R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":57,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0221281","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]}}}